Competent Cells Market Size, Share & Trends Analysis Report By Type (Chemically Competent Cells, Electrocompetent Cells, Ultracompetent Cells), By Application (Cloning, Protein Expression, Mutagenesis), By End-use, By Region, And Segment Forecasts, 2024 - 2030
This report can be delivered to the clients within 2 Business Days
Competent Cells Market Growth & Trends
The global competent cells market size is anticipated to reach USD 3.59 billion by 2030, exhibiting a CAGR of 8.10% from 2024 to 2030, according to a new report by Grand View Research, Inc. Increasing biopharmaceutical research, advancements in gene editing technologies, and the expanding field of synthetic biology is expected to propel market growth. Moreover, the biotechnology and pharmaceutical industries depend heavily on competent cells for the production of recombinant proteins, enzymes, and vaccines. The growing need for these products in medical treatments, research, and industrial applications fuels the demand for competent cells.
The COVID-19 pandemic has significantly boosted the market for competent cells, as companies increased their research and development efforts to address immediate health and scientific challenges. Competent cells, vital for tasks like molecular cloning, genetic engineering, and making recombinant proteins, have been in higher demand due to their key role in creating vaccines, diagnostic tests, and therapeutic research. The urgent need for vaccine manufacturing and treatments for COVID-19 has driven biotech and pharmaceutical companies to improve their cloning processes. These factors have impelled the growth of the market and are anticipated to propel exponentially over the forecast period.
In addition, technological advancements in cell preparation are projected to further propel the demand for competent cells. Technological advancements in the preparation and transformation efficiency of competent cells have significantly impacted the performance and reliability of competent cells, thus increasing the demand for researchers and industrial users. Additionally, genetic modifications and stress response pathway developments have further boosted transformation accomplishment, providing tailored solutions for specific applications, and advancing the utility of competent cells in various fields. These factors are thus projected to impel the growth of the market over the forecast period.
However, the high cost of producing and maintaining high-efficiency competent cells is considerable, which may limit their accessibility, especially for smaller research institutions and startups with limited budgets. This is anticipated to affect the adoption rate of competent cells in certain markets. Moreover, the process of preparing competent cells and accomplishing successful transformations could be technically complex and involve specialized knowledge and equipment. Thereby, hampering the growth of the market over the forecast period.
Competent Cells Market Report Highlights
Competent Cells Market Growth & Trends
The global competent cells market size is anticipated to reach USD 3.59 billion by 2030, exhibiting a CAGR of 8.10% from 2024 to 2030, according to a new report by Grand View Research, Inc. Increasing biopharmaceutical research, advancements in gene editing technologies, and the expanding field of synthetic biology is expected to propel market growth. Moreover, the biotechnology and pharmaceutical industries depend heavily on competent cells for the production of recombinant proteins, enzymes, and vaccines. The growing need for these products in medical treatments, research, and industrial applications fuels the demand for competent cells.
The COVID-19 pandemic has significantly boosted the market for competent cells, as companies increased their research and development efforts to address immediate health and scientific challenges. Competent cells, vital for tasks like molecular cloning, genetic engineering, and making recombinant proteins, have been in higher demand due to their key role in creating vaccines, diagnostic tests, and therapeutic research. The urgent need for vaccine manufacturing and treatments for COVID-19 has driven biotech and pharmaceutical companies to improve their cloning processes. These factors have impelled the growth of the market and are anticipated to propel exponentially over the forecast period.
In addition, technological advancements in cell preparation are projected to further propel the demand for competent cells. Technological advancements in the preparation and transformation efficiency of competent cells have significantly impacted the performance and reliability of competent cells, thus increasing the demand for researchers and industrial users. Additionally, genetic modifications and stress response pathway developments have further boosted transformation accomplishment, providing tailored solutions for specific applications, and advancing the utility of competent cells in various fields. These factors are thus projected to impel the growth of the market over the forecast period.
However, the high cost of producing and maintaining high-efficiency competent cells is considerable, which may limit their accessibility, especially for smaller research institutions and startups with limited budgets. This is anticipated to affect the adoption rate of competent cells in certain markets. Moreover, the process of preparing competent cells and accomplishing successful transformations could be technically complex and involve specialized knowledge and equipment. Thereby, hampering the growth of the market over the forecast period.
Competent Cells Market Report Highlights
- The chemically competent cells segment held the largest market share of 43.62% in 2023 due to their wide use in the field of recombinant DNA technology, and molecular biology. On the other hand, electrocompetent cells are anticipated to grow at the fastest CAGR over the forecast period.
- In 2023, the cloning segment is anticipated to dominate the market share for the application segment. However, the protein expression segment is expected to grow at the fastest CAGR of 9.04% over the forecast period driven by the increasing demand for recombinant proteins and enzymes required in various industrial and academic applications.
- The pharmaceutical & biotechnology companies segment dominated the end-use segment with the largest share in 2023 due to the rising demand for competent cells for drug discovery and development, along with the few qualitative tests required to fulfill the regulatory standards.
- The North America region dominated the market with a share of 34.13% owing to factors such as strong R&D in biotechnology, medicine, and therapeutics, along with substantial government funding. Asia Pacific is anticipated to grow at the fastest CAGR over the forecast period.
CHAPTER 1. METHODOLOGY AND SCOPE
1.1. Market Segmentation and Scope
1.2. Market Definitions
1.2.1. Type
1.2.2. Application
1.2.3. End Use
1.3. Information analysis
1.4. Market formulation & data visualization
1.5. Data validation & publishing
1.6. Information Procurement
1.6.1. Primary Research
1.7. Information or Data Analysis
1.8. Market Formulation & Validation
1.9. Market Model
1.10. Objectives
CHAPTER 2. EXECUTIVE SUMMARY
2.1. Market Outlook
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
CHAPTER 3. COMPETENT CELLS MARKET VARIABLES, TRENDS & SCOPE
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook.
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.1.1. Growing demand for recombinant proteins and antibodies
3.2.1.2. Growing biotechnology and pharmaceutical industries
3.2.1.3. Increasing research and development activities
3.2.2. Market restraint analysis
3.2.2.1. High Costs of Competent Cells
3.3. Competent Cells Market Analysis Tools
3.3.1. Industry Analysis - Porter’s Five Forces
3.3.2. PESTEL Analysis
3.3.3. COVID-19 Impact Analysis
CHAPTER 4. COMPETENT CELLS MARKET: TYPE ESTIMATES & TREND ANALYSIS
4.1. Segment Dashboard
4.2. Global Competent Cells Market Type Movement Analysis
4.3. Global Competent Cells Market Size & Trend Analysis, by Type, 2018 to 2030 (USD Million)
4.4. Chemically Competent Cells
4.4.1. Chemically competent cells market estimates and forecasts 2018 to 2030 (USD Million)
4.5. Electrocompetent Cells
4.5.1. Electrocompetent cells market estimates and forecasts 2018 to 2030 (USD Million)
4.6. Ultracompetent Cells
4.6.1. Ultracompetent cells market estimates and forecasts 2018 to 2030 (USD Million)
CHAPTER 5. COMPETENT CELLS MARKET: APPLICATION ESTIMATES & TREND ANALYSIS
5.1. Segment Dashboard
5.2. Global Competent Cells Market Application Movement Analysis
5.3. Global Competent Cells Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
5.4. Cloning
5.4.1. Cloning market estimates and forecasts 2018 to 2030 (USD Million)
5.5. Protein Expression
5.5.1. Protein expression market estimates and forecasts 2018 to 2030 (USD Million)
5.6. Mutagenesis
5.6.1. Mutagenesis market estimates and forecasts 2018 to 2030 (USD Million)
5.7. Others
5.7.1. Others market estimates and forecasts 2018 to 2030 (USD Million)
CHAPTER 6. COMPETENT CELLS MARKET: END-USE ESTIMATES & TREND ANALYSIS
6.1. Segment Dashboard
6.2. Global Competent Cells Market End-use Movement Analysis
6.3. Global Competent Cells Market Size & Trend Analysis, by End-use, 2018 to 2030 (USD Million)
6.4. Pharmaceutical & Biotechnology Companies
6.4.1. Pharmaceutical & biotechnology companies market estimates and forecasts 2018 to 2030 (USD Million)
6.5. Academic & Research Institutes
6.5.1. Academic & research institutes market estimates and forecasts 2018 to 2030 (USD Million)
6.6. Others
6.6.1. Others market estimates and forecasts 2018 to 2030 (USD Million)
CHAPTER 7. COMPETENT CELLS MARKET: REGIONAL ESTIMATES & TREND ANALYSIS
7.1. Regional Market Share Analysis, 2023 & 2030
7.2. Regional Market Dashboard
7.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
7.4. North America
7.4.1. North America market estimates and forecasts 2018 to 2030 (USD Million)
7.4.2. U.S.
7.4.2.1. Key country dynamics
7.4.2.2. Regulatory framework
7.4.2.3. Competitive scenario
7.4.2.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
7.4.3. Canada
7.4.3.1. Key country dynamics
7.4.3.2. Regulatory framework
7.4.3.3. Competitive scenario
7.4.3.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
7.4.4. Mexico
7.4.4.1. Key country dynamics
7.4.4.2. Regulatory framework
7.4.4.3. Competitive scenario
7.4.4.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
7.5. Europe
7.5.1. Europe market estimates and forecasts 2018 to 2030 (USD Million)
7.5.2. UK
7.5.2.1. Key country dynamics
7.5.2.2. Regulatory framework
7.5.2.3. Competitive scenario
7.5.2.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
7.5.3. Germany
7.5.3.1. Key country dynamics
7.5.3.2. Regulatory framework
7.5.3.3. Competitive scenario
7.5.3.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
7.5.4. France
7.5.4.1. Key country dynamics
7.5.4.2. Regulatory framework
7.5.4.3. Competitive scenario
7.5.4.4. France market estimates and forecasts 2018 to 2030 (USD Million)
7.5.5. Italy
7.5.5.1. Key country dynamics
7.5.5.2. Regulatory framework
7.5.5.3. Competitive scenario
7.5.5.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
7.5.6. Spain
7.5.6.1. Key country dynamics
7.5.6.2. Regulatory framework
7.5.6.3. Competitive scenario
7.5.6.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
7.5.7. Norway
7.5.7.1. Key country dynamics
7.5.7.2. Regulatory framework
7.5.7.3. Competitive scenario
7.5.7.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
7.5.8. Sweden
7.5.8.1. Key country dynamics
7.5.8.2. Regulatory framework
7.5.8.3. Competitive scenario
7.5.8.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
7.5.9. Denmark
7.5.9.1. Key country dynamics
7.5.9.2. Regulatory framework
7.5.9.3. Competitive scenario
7.5.9.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
7.6. Asia Pacific
7.6.1. Asia Pacific market estimates and forecasts 2018 to 2030 (USD Million)
7.6.2. Japan
7.6.2.1. Key country dynamics
7.6.2.2. Regulatory framework
7.6.2.3. Competitive scenario
7.6.2.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
7.6.3. China
7.6.3.1. Key country dynamics
7.6.3.2. Regulatory framework
7.6.3.3. Competitive scenario
7.6.3.4. China market estimates and forecasts 2018 to 2030 (USD Million)
7.6.4. India
7.6.4.1. Key country dynamics
7.6.4.2. Regulatory framework
7.6.4.3. Competitive scenario
7.6.4.4. India market estimates and forecasts 2018 to 2030 (USD Million)
7.6.5. Australia
7.6.5.1. Key country dynamics
7.6.5.2. Regulatory framework
7.6.5.3. Competitive scenario
7.6.5.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
7.6.6. South Korea
7.6.6.1. Key country dynamics
7.6.6.2. Regulatory framework
7.6.6.3. Competitive scenario
7.6.6.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
7.6.7. Thailand
7.6.7.1. Key country dynamics
7.6.7.2. Regulatory framework
7.6.7.3. Competitive scenario
7.6.7.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
7.7. Latin America
7.7.1. Latin America market estimates and forecasts 2018 to 2030 (USD Million)
7.7.2. Brazil
7.7.2.1. Key country dynamics
7.7.2.2. Regulatory framework
7.7.2.3. Competitive scenario
7.7.2.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
7.7.3. Argentina
7.7.3.1. Key country dynamics
7.7.3.2. Regulatory framework
7.7.3.3. Competitive scenario
7.7.3.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
7.8. MEA
7.8.1. MEA market estimates and forecasts 2018 to 2030 (USD Million)
7.8.2. South Africa
7.8.2.1. Key country dynamics
7.8.2.2. Regulatory framework
7.8.2.3. Competitive scenario
7.8.2.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
7.8.3. Saudi Arabia
7.8.3.1. Key country dynamics
7.8.3.2. Regulatory framework
7.8.3.3. Competitive scenario
7.8.3.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
7.8.4. UAE
7.8.4.1. Key country dynamics
7.8.4.2. Regulatory framework
7.8.4.3. Competitive scenario
7.8.4.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
7.8.5. Kuwait
7.8.5.1. Key country dynamics
7.8.5.2. Regulatory framework
7.8.5.3. Competitive scenario
7.8.5.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)
CHAPTER 8. COMPETITIVE LANDSCAPE
8.1. Company/Competition Categorization
8.2. Strategy Mapping
8.3. Company Market Position Analysis, 2023
8.4. Company Profiles/Listing
8.4.1. Thermo Fisher Scientific Inc.
8.4.1.1. Company overview
8.4.1.2. Financial performance
8.4.1.3. Product benchmarking
8.4.1.4. Strategic initiatives
8.4.2. Merck KGaA
8.4.2.1. Company overview
8.4.2.2. Financial performance
8.4.2.3. Product benchmarking
8.4.2.4. Strategic initiatives
8.4.3. Agilent Technologies, Inc.
8.4.3.1. Company overview
8.4.3.2. Financial performance
8.4.3.3. Product benchmarking
8.4.3.4. Strategic initiatives
8.4.4. Takara Bio Inc.
8.4.4.1. Company overview
8.4.4.2. Financial performance
8.4.4.3. Product benchmarking
8.4.4.4. Strategic initiatives
8.4.5. New England Biolabs (UK) Ltd.
8.4.5.1. Company overview
8.4.5.2. Financial performance
8.4.5.3. Product benchmarking
8.4.5.4. Strategic initiatives
8.4.6. Promega Corporation
8.4.6.1. Company overview
8.4.6.2. Financial performance
8.4.6.3. Product benchmarking
8.4.6.4. Strategic initiatives
8.4.7. Bio-Rad Laboratories
8.4.7.1. Company overview
8.4.7.2. Financial performance
8.4.7.3. Product benchmarking
8.4.7.4. Strategic initiatives
8.4.8. Roche Applied Science
8.4.8.1. Company overview
8.4.8.2. Financial performance
8.4.8.3. Product benchmarking
8.4.8.4. Strategic initiatives
8.4.9. Qiagen
8.4.9.1. Company overview
8.4.9.2. Financial performance
8.4.9.3. Product benchmarking
8.4.9.4. Strategic initiatives
8.4.10. SGI-DNA (Synthetic Genomics, Inc.)
8.4.10.1. Company overview
8.4.10.2. Financial performance
8.4.10.3. Product benchmarking
8.4.10.4. Strategic initiatives
1.1. Market Segmentation and Scope
1.2. Market Definitions
1.2.1. Type
1.2.2. Application
1.2.3. End Use
1.3. Information analysis
1.4. Market formulation & data visualization
1.5. Data validation & publishing
1.6. Information Procurement
1.6.1. Primary Research
1.7. Information or Data Analysis
1.8. Market Formulation & Validation
1.9. Market Model
1.10. Objectives
CHAPTER 2. EXECUTIVE SUMMARY
2.1. Market Outlook
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
CHAPTER 3. COMPETENT CELLS MARKET VARIABLES, TRENDS & SCOPE
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook.
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.1.1. Growing demand for recombinant proteins and antibodies
3.2.1.2. Growing biotechnology and pharmaceutical industries
3.2.1.3. Increasing research and development activities
3.2.2. Market restraint analysis
3.2.2.1. High Costs of Competent Cells
3.3. Competent Cells Market Analysis Tools
3.3.1. Industry Analysis - Porter’s Five Forces
3.3.2. PESTEL Analysis
3.3.3. COVID-19 Impact Analysis
CHAPTER 4. COMPETENT CELLS MARKET: TYPE ESTIMATES & TREND ANALYSIS
4.1. Segment Dashboard
4.2. Global Competent Cells Market Type Movement Analysis
4.3. Global Competent Cells Market Size & Trend Analysis, by Type, 2018 to 2030 (USD Million)
4.4. Chemically Competent Cells
4.4.1. Chemically competent cells market estimates and forecasts 2018 to 2030 (USD Million)
4.5. Electrocompetent Cells
4.5.1. Electrocompetent cells market estimates and forecasts 2018 to 2030 (USD Million)
4.6. Ultracompetent Cells
4.6.1. Ultracompetent cells market estimates and forecasts 2018 to 2030 (USD Million)
CHAPTER 5. COMPETENT CELLS MARKET: APPLICATION ESTIMATES & TREND ANALYSIS
5.1. Segment Dashboard
5.2. Global Competent Cells Market Application Movement Analysis
5.3. Global Competent Cells Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
5.4. Cloning
5.4.1. Cloning market estimates and forecasts 2018 to 2030 (USD Million)
5.5. Protein Expression
5.5.1. Protein expression market estimates and forecasts 2018 to 2030 (USD Million)
5.6. Mutagenesis
5.6.1. Mutagenesis market estimates and forecasts 2018 to 2030 (USD Million)
5.7. Others
5.7.1. Others market estimates and forecasts 2018 to 2030 (USD Million)
CHAPTER 6. COMPETENT CELLS MARKET: END-USE ESTIMATES & TREND ANALYSIS
6.1. Segment Dashboard
6.2. Global Competent Cells Market End-use Movement Analysis
6.3. Global Competent Cells Market Size & Trend Analysis, by End-use, 2018 to 2030 (USD Million)
6.4. Pharmaceutical & Biotechnology Companies
6.4.1. Pharmaceutical & biotechnology companies market estimates and forecasts 2018 to 2030 (USD Million)
6.5. Academic & Research Institutes
6.5.1. Academic & research institutes market estimates and forecasts 2018 to 2030 (USD Million)
6.6. Others
6.6.1. Others market estimates and forecasts 2018 to 2030 (USD Million)
CHAPTER 7. COMPETENT CELLS MARKET: REGIONAL ESTIMATES & TREND ANALYSIS
7.1. Regional Market Share Analysis, 2023 & 2030
7.2. Regional Market Dashboard
7.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
7.4. North America
7.4.1. North America market estimates and forecasts 2018 to 2030 (USD Million)
7.4.2. U.S.
7.4.2.1. Key country dynamics
7.4.2.2. Regulatory framework
7.4.2.3. Competitive scenario
7.4.2.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
7.4.3. Canada
7.4.3.1. Key country dynamics
7.4.3.2. Regulatory framework
7.4.3.3. Competitive scenario
7.4.3.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
7.4.4. Mexico
7.4.4.1. Key country dynamics
7.4.4.2. Regulatory framework
7.4.4.3. Competitive scenario
7.4.4.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
7.5. Europe
7.5.1. Europe market estimates and forecasts 2018 to 2030 (USD Million)
7.5.2. UK
7.5.2.1. Key country dynamics
7.5.2.2. Regulatory framework
7.5.2.3. Competitive scenario
7.5.2.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
7.5.3. Germany
7.5.3.1. Key country dynamics
7.5.3.2. Regulatory framework
7.5.3.3. Competitive scenario
7.5.3.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
7.5.4. France
7.5.4.1. Key country dynamics
7.5.4.2. Regulatory framework
7.5.4.3. Competitive scenario
7.5.4.4. France market estimates and forecasts 2018 to 2030 (USD Million)
7.5.5. Italy
7.5.5.1. Key country dynamics
7.5.5.2. Regulatory framework
7.5.5.3. Competitive scenario
7.5.5.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
7.5.6. Spain
7.5.6.1. Key country dynamics
7.5.6.2. Regulatory framework
7.5.6.3. Competitive scenario
7.5.6.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
7.5.7. Norway
7.5.7.1. Key country dynamics
7.5.7.2. Regulatory framework
7.5.7.3. Competitive scenario
7.5.7.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
7.5.8. Sweden
7.5.8.1. Key country dynamics
7.5.8.2. Regulatory framework
7.5.8.3. Competitive scenario
7.5.8.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
7.5.9. Denmark
7.5.9.1. Key country dynamics
7.5.9.2. Regulatory framework
7.5.9.3. Competitive scenario
7.5.9.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
7.6. Asia Pacific
7.6.1. Asia Pacific market estimates and forecasts 2018 to 2030 (USD Million)
7.6.2. Japan
7.6.2.1. Key country dynamics
7.6.2.2. Regulatory framework
7.6.2.3. Competitive scenario
7.6.2.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
7.6.3. China
7.6.3.1. Key country dynamics
7.6.3.2. Regulatory framework
7.6.3.3. Competitive scenario
7.6.3.4. China market estimates and forecasts 2018 to 2030 (USD Million)
7.6.4. India
7.6.4.1. Key country dynamics
7.6.4.2. Regulatory framework
7.6.4.3. Competitive scenario
7.6.4.4. India market estimates and forecasts 2018 to 2030 (USD Million)
7.6.5. Australia
7.6.5.1. Key country dynamics
7.6.5.2. Regulatory framework
7.6.5.3. Competitive scenario
7.6.5.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
7.6.6. South Korea
7.6.6.1. Key country dynamics
7.6.6.2. Regulatory framework
7.6.6.3. Competitive scenario
7.6.6.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
7.6.7. Thailand
7.6.7.1. Key country dynamics
7.6.7.2. Regulatory framework
7.6.7.3. Competitive scenario
7.6.7.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
7.7. Latin America
7.7.1. Latin America market estimates and forecasts 2018 to 2030 (USD Million)
7.7.2. Brazil
7.7.2.1. Key country dynamics
7.7.2.2. Regulatory framework
7.7.2.3. Competitive scenario
7.7.2.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
7.7.3. Argentina
7.7.3.1. Key country dynamics
7.7.3.2. Regulatory framework
7.7.3.3. Competitive scenario
7.7.3.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
7.8. MEA
7.8.1. MEA market estimates and forecasts 2018 to 2030 (USD Million)
7.8.2. South Africa
7.8.2.1. Key country dynamics
7.8.2.2. Regulatory framework
7.8.2.3. Competitive scenario
7.8.2.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
7.8.3. Saudi Arabia
7.8.3.1. Key country dynamics
7.8.3.2. Regulatory framework
7.8.3.3. Competitive scenario
7.8.3.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
7.8.4. UAE
7.8.4.1. Key country dynamics
7.8.4.2. Regulatory framework
7.8.4.3. Competitive scenario
7.8.4.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
7.8.5. Kuwait
7.8.5.1. Key country dynamics
7.8.5.2. Regulatory framework
7.8.5.3. Competitive scenario
7.8.5.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)
CHAPTER 8. COMPETITIVE LANDSCAPE
8.1. Company/Competition Categorization
8.2. Strategy Mapping
8.3. Company Market Position Analysis, 2023
8.4. Company Profiles/Listing
8.4.1. Thermo Fisher Scientific Inc.
8.4.1.1. Company overview
8.4.1.2. Financial performance
8.4.1.3. Product benchmarking
8.4.1.4. Strategic initiatives
8.4.2. Merck KGaA
8.4.2.1. Company overview
8.4.2.2. Financial performance
8.4.2.3. Product benchmarking
8.4.2.4. Strategic initiatives
8.4.3. Agilent Technologies, Inc.
8.4.3.1. Company overview
8.4.3.2. Financial performance
8.4.3.3. Product benchmarking
8.4.3.4. Strategic initiatives
8.4.4. Takara Bio Inc.
8.4.4.1. Company overview
8.4.4.2. Financial performance
8.4.4.3. Product benchmarking
8.4.4.4. Strategic initiatives
8.4.5. New England Biolabs (UK) Ltd.
8.4.5.1. Company overview
8.4.5.2. Financial performance
8.4.5.3. Product benchmarking
8.4.5.4. Strategic initiatives
8.4.6. Promega Corporation
8.4.6.1. Company overview
8.4.6.2. Financial performance
8.4.6.3. Product benchmarking
8.4.6.4. Strategic initiatives
8.4.7. Bio-Rad Laboratories
8.4.7.1. Company overview
8.4.7.2. Financial performance
8.4.7.3. Product benchmarking
8.4.7.4. Strategic initiatives
8.4.8. Roche Applied Science
8.4.8.1. Company overview
8.4.8.2. Financial performance
8.4.8.3. Product benchmarking
8.4.8.4. Strategic initiatives
8.4.9. Qiagen
8.4.9.1. Company overview
8.4.9.2. Financial performance
8.4.9.3. Product benchmarking
8.4.9.4. Strategic initiatives
8.4.10. SGI-DNA (Synthetic Genomics, Inc.)
8.4.10.1. Company overview
8.4.10.2. Financial performance
8.4.10.3. Product benchmarking
8.4.10.4. Strategic initiatives
LIST OF TABLES
Table 1 List of abbreviation
Table 2 Global competent cells market, by region, 2018 - 2030 (USD Million)
Table 3 Global competent cells market, by type, 2018 - 2030 (USD Million)
Table 4 Global competent cells market, by application, 2018 - 2030 (USD Million)
Table 5 Global competent cells market, by end-use, 2018 - 2030 (USD Million)
Table 6 North America competent cells market, by country, 2018 - 2030 (USD Million)
Table 7 North America competent cells market, by type, 2018 - 2030 (USD Million)
Table 8 North America competent cells market, by application, 2018 - 2030 (USD Million)
Table 9 North America competent cells market, by end-use, 2018 - 2030 (USD Million)
Table 10 U.S. competent cells market, by type, 2018 - 2030 (USD Million)
Table 11 U.S. competent cells market, by application, 2018 - 2030 (USD Million)
Table 12 U.S. competent cells market, by end-use, 2018 - 2030 (USD Million)
Table 13 Canada competent cells market, by type, 2018 - 2030 (USD Million)
Table 14 Canada competent cells market, by application, 2018 - 2030 (USD Million)
Table 15 Canada competent cells market, by end-use, 2018 - 2030 (USD Million)
Table 16 Mexico competent cells market, by type, 2018 - 2030 (USD Million)
Table 17 Mexico competent cells market, by application, 2018 - 2030 (USD Million)
Table 18 Mexico competent cells market, by end-use, 2018 - 2030 (USD Million)
Table 19 Europe competent cells market, by country, 2018 - 2030 (USD Million)
Table 20 Europe competent cells market, by type, 2018 - 2030 (USD Million)
Table 21 Europe competent cells market, by application, 2018 - 2030 (USD Million)
Table 22 Europe competent cells market, by end-use, 2018 - 2030 (USD Million)
Table 23 Germany competent cells market, by type, 2018 - 2030 (USD Million)
Table 24 Germany competent cells market, by application, 2018 - 2030 (USD Million)
Table 25 Germany competent cells market, by end-use, 2018 - 2030 (USD Million)
Table 26 UK competent cells market, by type, 2018 - 2030 (USD Million)
Table 27 UK competent cells market, by application, 2018 - 2030 (USD Million)
Table 28 UK competent cells market, by end-use, 2018 - 2030 (USD Million)
Table 29 France competent cells market, by type, 2018 - 2030 (USD Million)
Table 30 France competent cells market, by application, 2018 - 2030 (USD Million)
Table 31 France competent cells market, by end-use, 2018 - 2030 (USD Million)
Table 32 Italy competent cells market, by type, 2018 - 2030 (USD Million)
Table 33 Italy competent cells market, by application, 2018 - 2030 (USD Million)
Table 34 Italy competent cells market, by end-use, 2018 - 2030 (USD Million)
Table 35 Spain competent cells market, by type, 2018 - 2030 (USD Million)
Table 36 Spain competent cells market, by application, 2018 - 2030 (USD Million)
Table 37 Spain competent cells market, by end-use, 2018 - 2030 (USD Million)
Table 38 Denmark competent cells market, by type, 2018 - 2030 (USD Million)
Table 39 Denmark competent cells market, by application, 2018 - 2030 (USD Million)
Table 40 Denmark competent cells market, by end-use, 2018 - 2030 (USD Million)
Table 41 Sweden competent cells market, by type, 2018 - 2030 (USD Million)
Table 42 Sweden competent cells market, by application, 2018 - 2030 (USD Million)
Table 43 Sweden competent cells market, by end-use, 2018 - 2030 (USD Million)
Table 44 Norway competent cells market, by type, 2018 - 2030 (USD Million)
Table 45 Norway competent cells market, by application, 2018 - 2030 (USD Million)
Table 46 Norway competent cells market, by end-use, 2018 - 2030 (USD Million)
Table 47 Asia Pacific competent cells market, by country, 2018 - 2030 (USD Million)
Table 48 Asia Pacific competent cells market, by type, 2018 - 2030 (USD Million)
Table 49 Asia Pacific competent cells market, by application, 2018 - 2030 (USD Million)
Table 50 Asia Pacific competent cells market, by end-use, 2018 - 2030 (USD Million)
Table 51 China competent cells market, by application, 2018 - 2030 (USD Million)
Table 52 China competent cells market, by type, 2018 - 2030 (USD Million)
Table 53 China competent cells market, by end-use, 2018 - 2030 (USD Million)
Table 54 Japan competent cells market, by type, 2018 - 2030 (USD Million)
Table 55 Japan competent cells market, by application, 2018 - 2030 (USD Million)
Table 56 Japan competent cells market, by end-use, 2018 - 2030 (USD Million)
Table 57 India competent cells market, by type, 2018 - 2030 (USD Million)
Table 58 India competent cells market, by application, 2018 - 2030 (USD Million)
Table 59 India competent cells market, by end-use, 2018 - 2030 (USD Million)
Table 60 South Korea competent cells market, by type, 2018 - 2030 (USD Million)
Table 61 South Korea competent cells market, by application, 2018 - 2030 (USD Million)
Table 62 South Korea competent cells market, by end-use, 2018 - 2030 (USD Million)
Table 63 Australia competent cells market, by type, 2018 - 2030 (USD Million)
Table 64 Australia competent cells market, by application, 2018 - 2030 (USD Million)
Table 65 Australia competent cells market, by end-use, 2018 - 2030 (USD Million)
Table 66 Thailand competent cells market, by type, 2018 - 2030 (USD Million)
Table 67 Thailand competent cells market, by application, 2018 - 2030 (USD Million)
Table 68 Thailand competent cells market, by end-use, 2018 - 2030 (USD Million)
Table 69 Latin America competent cells market, by country, 2018 - 2030 (USD Million)
Table 70 Latin America competent cells market, by type, 2018 - 2030 (USD Million)
Table 71 Latin America competent cells market, by application, 2018 - 2030 (USD Million)
Table 72 Latin America competent cells market, by end-use, 2018 - 2030 (USD Million)
Table 73 Brazil competent cells market, by type, 2018 - 2030 (USD Million)
Table 74 Brazil competent cells market, by application, 2018 - 2030 (USD Million)
Table 75 Brazil competent cells market, by end-use, 2018 - 2030 (USD Million)
Table 76 Argentina competent cells market, by type, 2018 - 2030 (USD Million)
Table 77 Argentina competent cells market, by application, 2018 - 2030 (USD Million)
Table 78 Argentina competent cells market, by end-use, 2018 - 2030 (USD Million)
Table 79 MEA competent cells market, by country, 2018 - 2030 (USD Million)
Table 80 MEA competent cells market, by type, 2018 - 2030 (USD Million)
Table 81 MEA competent cells market, by application, 2018 - 2030 (USD Million)
Table 82 MEA competent cells market, by end-use, 2018 - 2030 (USD Million)
Table 83 South Africa competent cells market, by type, 2018 - 2030 (USD Million)
Table 84 South Africa competent cells market, by application, 2018 - 2030 (USD Million)
Table 85 South Africa competent cells market, by end-use, 2018 - 2030 (USD Million)
Table 86 Saudi Arabia competent cells market, by type, 2018 - 2030 (USD Million)
Table 87 Saudi Arabia competent cells market, by application, 2018 - 2030 (USD Million)
Table 88 Saudi Arabia competent cells market, by end-use, 2018 - 2030 (USD Million)
Table 89 UAE competent cells market, by type, 2018 - 2030 (USD Million)
Table 90 UAE competent cells market, by application, 2018 - 2030 (USD Million)
Table 91 UAE competent cells market, by end-use, 2018 - 2030 (USD Million)
Table 92 Kuwait competent cells market, by type, 2018 - 2030 (USD Million)
Table 93 Kuwait competent cells market, by application, 2018 - 2030 (USD Million)
Table 94 Kuwait competent cells market, by end-use, 2018 - 2030 (USD Million)
Table 1 List of abbreviation
Table 2 Global competent cells market, by region, 2018 - 2030 (USD Million)
Table 3 Global competent cells market, by type, 2018 - 2030 (USD Million)
Table 4 Global competent cells market, by application, 2018 - 2030 (USD Million)
Table 5 Global competent cells market, by end-use, 2018 - 2030 (USD Million)
Table 6 North America competent cells market, by country, 2018 - 2030 (USD Million)
Table 7 North America competent cells market, by type, 2018 - 2030 (USD Million)
Table 8 North America competent cells market, by application, 2018 - 2030 (USD Million)
Table 9 North America competent cells market, by end-use, 2018 - 2030 (USD Million)
Table 10 U.S. competent cells market, by type, 2018 - 2030 (USD Million)
Table 11 U.S. competent cells market, by application, 2018 - 2030 (USD Million)
Table 12 U.S. competent cells market, by end-use, 2018 - 2030 (USD Million)
Table 13 Canada competent cells market, by type, 2018 - 2030 (USD Million)
Table 14 Canada competent cells market, by application, 2018 - 2030 (USD Million)
Table 15 Canada competent cells market, by end-use, 2018 - 2030 (USD Million)
Table 16 Mexico competent cells market, by type, 2018 - 2030 (USD Million)
Table 17 Mexico competent cells market, by application, 2018 - 2030 (USD Million)
Table 18 Mexico competent cells market, by end-use, 2018 - 2030 (USD Million)
Table 19 Europe competent cells market, by country, 2018 - 2030 (USD Million)
Table 20 Europe competent cells market, by type, 2018 - 2030 (USD Million)
Table 21 Europe competent cells market, by application, 2018 - 2030 (USD Million)
Table 22 Europe competent cells market, by end-use, 2018 - 2030 (USD Million)
Table 23 Germany competent cells market, by type, 2018 - 2030 (USD Million)
Table 24 Germany competent cells market, by application, 2018 - 2030 (USD Million)
Table 25 Germany competent cells market, by end-use, 2018 - 2030 (USD Million)
Table 26 UK competent cells market, by type, 2018 - 2030 (USD Million)
Table 27 UK competent cells market, by application, 2018 - 2030 (USD Million)
Table 28 UK competent cells market, by end-use, 2018 - 2030 (USD Million)
Table 29 France competent cells market, by type, 2018 - 2030 (USD Million)
Table 30 France competent cells market, by application, 2018 - 2030 (USD Million)
Table 31 France competent cells market, by end-use, 2018 - 2030 (USD Million)
Table 32 Italy competent cells market, by type, 2018 - 2030 (USD Million)
Table 33 Italy competent cells market, by application, 2018 - 2030 (USD Million)
Table 34 Italy competent cells market, by end-use, 2018 - 2030 (USD Million)
Table 35 Spain competent cells market, by type, 2018 - 2030 (USD Million)
Table 36 Spain competent cells market, by application, 2018 - 2030 (USD Million)
Table 37 Spain competent cells market, by end-use, 2018 - 2030 (USD Million)
Table 38 Denmark competent cells market, by type, 2018 - 2030 (USD Million)
Table 39 Denmark competent cells market, by application, 2018 - 2030 (USD Million)
Table 40 Denmark competent cells market, by end-use, 2018 - 2030 (USD Million)
Table 41 Sweden competent cells market, by type, 2018 - 2030 (USD Million)
Table 42 Sweden competent cells market, by application, 2018 - 2030 (USD Million)
Table 43 Sweden competent cells market, by end-use, 2018 - 2030 (USD Million)
Table 44 Norway competent cells market, by type, 2018 - 2030 (USD Million)
Table 45 Norway competent cells market, by application, 2018 - 2030 (USD Million)
Table 46 Norway competent cells market, by end-use, 2018 - 2030 (USD Million)
Table 47 Asia Pacific competent cells market, by country, 2018 - 2030 (USD Million)
Table 48 Asia Pacific competent cells market, by type, 2018 - 2030 (USD Million)
Table 49 Asia Pacific competent cells market, by application, 2018 - 2030 (USD Million)
Table 50 Asia Pacific competent cells market, by end-use, 2018 - 2030 (USD Million)
Table 51 China competent cells market, by application, 2018 - 2030 (USD Million)
Table 52 China competent cells market, by type, 2018 - 2030 (USD Million)
Table 53 China competent cells market, by end-use, 2018 - 2030 (USD Million)
Table 54 Japan competent cells market, by type, 2018 - 2030 (USD Million)
Table 55 Japan competent cells market, by application, 2018 - 2030 (USD Million)
Table 56 Japan competent cells market, by end-use, 2018 - 2030 (USD Million)
Table 57 India competent cells market, by type, 2018 - 2030 (USD Million)
Table 58 India competent cells market, by application, 2018 - 2030 (USD Million)
Table 59 India competent cells market, by end-use, 2018 - 2030 (USD Million)
Table 60 South Korea competent cells market, by type, 2018 - 2030 (USD Million)
Table 61 South Korea competent cells market, by application, 2018 - 2030 (USD Million)
Table 62 South Korea competent cells market, by end-use, 2018 - 2030 (USD Million)
Table 63 Australia competent cells market, by type, 2018 - 2030 (USD Million)
Table 64 Australia competent cells market, by application, 2018 - 2030 (USD Million)
Table 65 Australia competent cells market, by end-use, 2018 - 2030 (USD Million)
Table 66 Thailand competent cells market, by type, 2018 - 2030 (USD Million)
Table 67 Thailand competent cells market, by application, 2018 - 2030 (USD Million)
Table 68 Thailand competent cells market, by end-use, 2018 - 2030 (USD Million)
Table 69 Latin America competent cells market, by country, 2018 - 2030 (USD Million)
Table 70 Latin America competent cells market, by type, 2018 - 2030 (USD Million)
Table 71 Latin America competent cells market, by application, 2018 - 2030 (USD Million)
Table 72 Latin America competent cells market, by end-use, 2018 - 2030 (USD Million)
Table 73 Brazil competent cells market, by type, 2018 - 2030 (USD Million)
Table 74 Brazil competent cells market, by application, 2018 - 2030 (USD Million)
Table 75 Brazil competent cells market, by end-use, 2018 - 2030 (USD Million)
Table 76 Argentina competent cells market, by type, 2018 - 2030 (USD Million)
Table 77 Argentina competent cells market, by application, 2018 - 2030 (USD Million)
Table 78 Argentina competent cells market, by end-use, 2018 - 2030 (USD Million)
Table 79 MEA competent cells market, by country, 2018 - 2030 (USD Million)
Table 80 MEA competent cells market, by type, 2018 - 2030 (USD Million)
Table 81 MEA competent cells market, by application, 2018 - 2030 (USD Million)
Table 82 MEA competent cells market, by end-use, 2018 - 2030 (USD Million)
Table 83 South Africa competent cells market, by type, 2018 - 2030 (USD Million)
Table 84 South Africa competent cells market, by application, 2018 - 2030 (USD Million)
Table 85 South Africa competent cells market, by end-use, 2018 - 2030 (USD Million)
Table 86 Saudi Arabia competent cells market, by type, 2018 - 2030 (USD Million)
Table 87 Saudi Arabia competent cells market, by application, 2018 - 2030 (USD Million)
Table 88 Saudi Arabia competent cells market, by end-use, 2018 - 2030 (USD Million)
Table 89 UAE competent cells market, by type, 2018 - 2030 (USD Million)
Table 90 UAE competent cells market, by application, 2018 - 2030 (USD Million)
Table 91 UAE competent cells market, by end-use, 2018 - 2030 (USD Million)
Table 92 Kuwait competent cells market, by type, 2018 - 2030 (USD Million)
Table 93 Kuwait competent cells market, by application, 2018 - 2030 (USD Million)
Table 94 Kuwait competent cells market, by end-use, 2018 - 2030 (USD Million)
LIST OF FIGURES
Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Market formulation & validation
Fig. 4 Competent cells market: Market outlook
Fig. 5 Competent cells market: Segment outlook
Fig. 6 Competent cells market: Competitive landscape outlook
Fig. 7 Parent market outlook
Fig. 8 Competent cells market driver impact
Fig. 9 Competent cells market restraint impact
Fig. 10 Competent cells market: Type outlook and key takeaways
Fig. 11 Competent cells market: Type movement analysis
Fig. 12 Chemically competent cells market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 13 Electrocompetent cells market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 14 Ultracompetent cells market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 15 Competent cells market: Application outlook and key takeaways
Fig. 16 Competent cells market: Application movement analysis
Fig. 17 Cloning market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 18 Protein expression market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 19 Mutagenesis market estimates and forecasts,2018 - 2030 (USD Million)
Fig. 20 Others market estimates and forecasts,2018 - 2030 (USD Million)
Fig. 21 Competent cells market: End-use outlook and key takeaways
Fig. 22 Competent cells market: End-use movement analysis
Fig. 23 Pharmaceutical & biotechnology companies market estimates and forecasts,2018 - 2030 (USD Million)
Fig. 24 Academic & research institutes market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 25 Others market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 26 Global competent cells market: Regional outlook and key takeaways
Fig. 27 Global competent cells market: Regional movement analysis
Fig. 28 North America market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 29 U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 30 Canada market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 31 Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 32 Europe market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 33 UK market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 34 Germany market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 35 France market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 36 Italy market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 37 Spain market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 38 Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 39 Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 40 Norway market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 41 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 42 China market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 43 Japan market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 44 India market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 45 Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 46 South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 47 Australia market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 48 Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 49 Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 50 Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 51 Middle East and Africa market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 52 South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 53 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 54 UAE market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 55 Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Market formulation & validation
Fig. 4 Competent cells market: Market outlook
Fig. 5 Competent cells market: Segment outlook
Fig. 6 Competent cells market: Competitive landscape outlook
Fig. 7 Parent market outlook
Fig. 8 Competent cells market driver impact
Fig. 9 Competent cells market restraint impact
Fig. 10 Competent cells market: Type outlook and key takeaways
Fig. 11 Competent cells market: Type movement analysis
Fig. 12 Chemically competent cells market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 13 Electrocompetent cells market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 14 Ultracompetent cells market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 15 Competent cells market: Application outlook and key takeaways
Fig. 16 Competent cells market: Application movement analysis
Fig. 17 Cloning market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 18 Protein expression market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 19 Mutagenesis market estimates and forecasts,2018 - 2030 (USD Million)
Fig. 20 Others market estimates and forecasts,2018 - 2030 (USD Million)
Fig. 21 Competent cells market: End-use outlook and key takeaways
Fig. 22 Competent cells market: End-use movement analysis
Fig. 23 Pharmaceutical & biotechnology companies market estimates and forecasts,2018 - 2030 (USD Million)
Fig. 24 Academic & research institutes market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 25 Others market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 26 Global competent cells market: Regional outlook and key takeaways
Fig. 27 Global competent cells market: Regional movement analysis
Fig. 28 North America market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 29 U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 30 Canada market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 31 Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 32 Europe market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 33 UK market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 34 Germany market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 35 France market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 36 Italy market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 37 Spain market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 38 Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 39 Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 40 Norway market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 41 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 42 China market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 43 Japan market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 44 India market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 45 Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 46 South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 47 Australia market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 48 Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 49 Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 50 Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 51 Middle East and Africa market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 52 South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 53 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 54 UAE market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 55 Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)
